Annual report pursuant to Section 13 and 15(d)

EQUITY TRANSACTIONS (Details - Option Outstanding)

v3.22.2
EQUITY TRANSACTIONS (Details - Option Outstanding) - Equity Option [Member]
12 Months Ended
Mar. 31, 2022
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Options vested 267,221
Weighted average exercise price options vested | $ / shares $ 2.51
Weighted average remaining contractual term options vested 8 years 2 months 15 days
Options expected to vest 1,398,727
Weighted average exercise price options expected to vest | $ / shares $ 2.27
Weighted average remaining contractual term options expected to vest 9 years 2 months 1 day
Total options outstanding 1,665,948